Quality-of-life assessment in cancer treatment protocols: Research issues in protocol development

Journal of the National Cancer Institute

Volumn 84, Issue 8, 1992, Pages 575-579

  Gotay, Carolyn Cook ^a   Korn, Edward L ^b   Mccabe, Mary S ^b   Moore, Timothy D ^b   Cheson, Bruce D ^b  

^a EMMES CORPORATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; HUMAN; INTERVIEW; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PATIENT CARE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; TREATMENT PLANNING;

CLINICAL PROTOCOLS; HUMAN; NEOPLASMS; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 0026552555     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.8.575     Document Type: Article

References (35)

1. Spilker B, ed: Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990
2. Tchekmedyian NS, Cella DF, eds: Quality of Life in Current Oncology Practice and Research. Oncology 4:1990
3. Office of Disease Prevention, Office of Medical Applications of Research, National Cancer Institute: Workshop on Quality of Life Research in Cancer Clinical Trials. Bethesda, Md: NCI, July 16-17, 1990
4. Office of Science Policy and Legislation, National Institutes of Health: Workshop on Quality of Life Assessment: Practice, Problems, &and Promise. Bethesda, Md: NIH, October 15-17, 1990
5. O’Shaughnessy JA, Wittes RE, Burke G, et al: Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol 9:2225-2232, 1991
6. Mojnpour CM, Feigl P, Metch B, et al: Quality of life end points in cancer clinical trials: Review and recommendations. J Natl Cancer Inst 81:485-495, 1989
7. Hollandsworth JG: Evaluating the impact of medical treatment on the quality of life: A 5-year update. Soc Sci Med 26:425-434, 1988
8. Aaronson NK: Implementation problems in clinical trial-based quality-of- life investigations: The European Organization for Research and Treatment of Cancer experience. Presented at the National Institutes of Health (Office of Science Policy and Legislation) Workshop on Quality of Life Assessment: Practice, Problems, &and Promise, Bethesda, Md, October 15-17, 1990
9. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life in metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630-633, 1988
10. Ganz PA, Haskell CM, Figlin RA, et al: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Kamofsky Performance Status and The Functional Living Index—Cancer. Cancer 61:849-856.1988
11. Yancik R, Edwards BK, Yates JW: Assessing the quality of life of cancer patients: Practical issues in study implementation. J Psychosocial Oncol 7:59-74, 1989
12. Moinpour CM, Hayden KA, Thompson IA, et al: Quality of life assessment in Southwest Oncology Group trials. Oncology 4:79-84, 89, 1990
13. Kornblith AB, Anderson J, Cella DF, et al: Quality of life assessment of Hodgkin’s disease survivors: A model for cooperative clinical trials. Oncology 4:93-101. 1990
14. Poon MA, O'Connell MJ, Moertel CG, et al: Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal cancer. J Clin Oncol 7:1407-1418, 1989
15. Walczak JR, Brady M: Comparison of quality of life (QOL) in ovarian cancer patients participating in a national cooperative group phase III randomized trial. Proc ASCO 10.A1185, 1991
16. Aaronson NK, Barker W, Stewart AL, et al: Multidimensional approach to the measurement of quality of life in lung cancer trials. In The Quality of Life of Cancer Patients (Aaronson NK, Beckmann JH, Bemheim JL, et al, eds). New York: Raven Press, 1987, pp 63-82
17. Donovan K, Sanson-Fisher RW, Redman S: Measuring quality of life in cancer patients. J Clin Oncol 7:959-968, 1989
18. National Cancer Institute of Canada: Writing Guidelines for Inclusion of Quality of Life Measures in Protocols for Phase III Clinical Trials Conducted by the Clinical Trials Group of the NCI-C. (undated) Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute: Investigator’s Handbook. Bethesda, Md: NCI, 1986
19. Calman KC: Definitions and dimensions of quality of life. In The Quality of Life of Cancer Patients (Aaronson NK, Beckmann JH, Bemheim JL, et al, eds). New York: Raven Press, 1987, pp 1-10
20. Cella DF, Cherin EA: Quality of life during and after cancer treatment. ComprTher 14:69-75, 1988
21. Shumaker SA, Anderson RT, Czajkowski SM: Psychological tests and scales. In Quality of Life Assessments in Clinical Trials. (Spilker B, ed). New York: Raven Press, 1990, pp 95—113
22. Schipper H: Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology 4:51-57, 1990
23. McDowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford Univ Press, 1987
24. Stewart AL, Hays RD, Ware JE Jr: The MOS short-fonm general health survey: Reliability and validity in a patient population. Med Care 26:724-735, 1988
25. Bergner M, Bobbitt RA, Carter WB, et al: The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19:787-805, 1981
26. Ferrans CE, Powers MJ: Quality of Life Index: Development and psychometric properties. ANS Adv Nurs Sci 8:15-24, 1985
27. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: Development and validation. J Clin Oncol 2:472-483, 1984
28. Cella DF, Lee-Riordan D, Silberman M, et al: Quality of life in advanced cancer: Three new disease-specific measures. Proc ASCO Oncol 8:A1225, 1989
29. Schag CC, Heinrich RL, Ganz PA: Cancer Inventory of Problem Situations: An instrument for assessing cancer patients’ rehabilitation needs. J Psychosoc Oncol 1:11-24, 1983
30. Buccheri GF, Ferrigno D, Curcio A, et al: Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small-cell lung cancer and stable disease after two or three cycles of MACC. Cancer 63:428-432, 1989
31. Ganz PA, Figlin RA, Haskell CM, et al: Supportive care versus supportive care and combination chemotherapy on metastatic non-small-cell lung cancer. Cancer 63:1271-1278, 1989
32. Young RC, Longo DL, Glatstein E, et al: The treatment of indolent lymphomas: Watchful waiting v aggressive combined modality treatment. Semin Hematol 25(suppl II): 11 -16, 1988
33. Barofsky I, Sugarbaker PH: Cancer. In Quality of Life Assessments in Clinical Trials (Spilker B, ed). New York: Raven Press, 1990, pp 419-439
34. Cella DF, Tulsky DS: Measuring quality of life today: Methodological aspects. Oncology 4:29-38, 1990
35. Ghiselli EE, Campbell JP, Zedeck S: Measurement Theory for the Behavioral Sciences. San Francisco: Freeman, 1981